Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, antibodies, anticoagulant drugs, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, sickle cell disease, viral, Bleeding and Clotting, Diseases, Lymphoma (any), Non-Biological, sickle cell trait, Therapies, Genetic Disorders, ITP, Pediatric, red blood cells, B-Cell Lymphoma, Biological Processes, DLBCL, Hemoglobinopathies, Thrombosis, devices, gene therapy, Polycythemia vera, Technology and Procedures, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, Quality Improvement , Thrombotic Disorders, VTE
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, antibodies, anticoagulant drugs, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, sickle cell disease, viral, Bleeding and Clotting, Diseases, Lymphoma (any), Non-Biological, sickle cell trait, Therapies, Genetic Disorders, ITP, Pediatric, red blood cells, B-Cell Lymphoma, Biological Processes, DLBCL, Hemoglobinopathies, Thrombosis, devices, gene therapy, Polycythemia vera, Technology and Procedures, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, Quality Improvement , Thrombotic Disorders, VTE
Monday, December 7, 2020: 7:00 AM-3:30 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH